<Suppliers Price>

Periplocymarin

Names

[ CAS No. ]:
32476-67-8

[ Name ]:
Periplocymarin

[Synonym ]:
periplocymarin

Biological Activity

[Description]:

Periplocymarin, a cardiac glycoside isolated from Periploca sepium and Periploca graeca, is a potential anti-cancer compound[1][2].

[Related Catalog]:

Research Areas >> Cancer
Signaling Pathways >> Others >> Others

[In Vitro]

Periplocymarin inhibits proliferation of PC3, U937, HCT-8, Bel-7402, BGC823, A549, and A2780 cell lines in vitro with IC50 values of 0.02-0.29 µM[2].

[References]

[1]. Martey ON, et al. Periplocymarin is a potential natural compound for drug development: highly permeable with absence of P-glycoprotein efflux and cytochrome P450 inhibitions. Biopharm Drug Dispos. 2014 May;35(4):195-206.

[2]. Redox-responsive PEGylated self-assembled prodrug-nanoparticles formed by single disulfidebond bridge periplocymarin-vitamin E conjugate for liver cancer chemotherapy. Drug Deliv. 2017 Nov;24(1):1170-1178.

Chemical & Physical Properties

[ Density]:
1.27±0.1 g/cm3 (20 ºC 760 Torr)

[ Boiling Point ]:
690.9±55.0℃ at 760 mmHg

[ Melting Point ]:
209-211 ºC

[ Molecular Formula ]:
C30H46O8

[ Molecular Weight ]:
534.68100

[ Exact Mass ]:
534.31900

[ PSA ]:
114.68000

[ LogP ]:
3.25430

[ Water Solubility ]:
Very slightly soluble (0.43 g/L) (25 ºC)

Toxicological Information

CHEMICAL IDENTIFICATION

RTECS NUMBER :
FH4920610
CHEMICAL NAME :
5-beta-Card-20(22)-enolide, 3-beta-((2,6-dideoxy-3-O-methyl-beta-D-ribo-hexopyran osyl)oxy)- 5,14-dihydroxy-
CAS REGISTRY NUMBER :
32476-67-8
LAST UPDATED :
199304
DATA ITEMS CITED :
1
MOLECULAR FORMULA :
C30-H46-O8
MOLECULAR WEIGHT :
534.76
WISWESSER LINE NOTATION :
L E5 B666TJ A1 E1 IQ MQ F- DT5OV EHJ& OO- FT6OTJ B1 CQ DO1

HEALTH HAZARD DATA

ACUTE TOXICITY DATA

TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Intravenous
SPECIES OBSERVED :
Mammal - cat
DOSE/DURATION :
155 ug/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
JPETAB Journal of Pharmacology and Experimental Therapeutics. (Williams & Wilkins Co., 428 E. Preston St., Baltimore, MD 21202) V.1- 1909/10- Volume(issue)/page/year: 74,223,1942

Related Compounds

The content on this webpage is sourced from various professional data sources. If you have any questions or concerns regarding the content, please feel free to contact service1@chemsrc.com.